000 | 01323 a2200313 4500 | ||
---|---|---|---|
005 | 20250514201640.0 | ||
264 | 0 | _c20050804 | |
008 | 200508s 0 0 eng d | ||
022 | _a1173-8804 | ||
024 | 7 |
_a10.2165/00063030-200418050-00004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNanji, Sulaiman A | |
245 | 0 | 0 |
_aIslet transplantation in patients with diabetes mellitus: choice of immunosuppression. _h[electronic resource] |
260 |
_bBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy _c2004 |
||
300 |
_a315-28 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aCanada |
650 | 0 | 4 |
_aClinical Protocols _xstandards |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aDiabetes Mellitus _xdiagnosis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppression Therapy _xmethods |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aIslets of Langerhans Transplantation _xmethods |
650 | 0 | 4 |
_aTransplantation Tolerance _xdrug effects |
700 | 1 | _aShapiro, A M James | |
773 | 0 |
_tBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy _gvol. 18 _gno. 5 _gp. 315-28 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2165/00063030-200418050-00004 _zAvailable from publisher's website |
999 |
_c15070540 _d15070540 |